I. Introduction
===============

Chondrosarcoma is a malignant tumor that originates from cartilaginous cells and is characterized by the formation of cartilage, but not bone[@B1]. It appears as a common primary bone tumor of the pelvis, ribs, and femur, but is rare in the head and neck regions[@B2]. Therefore, chondrosarcoma of the jaw is uncommon in the head and neck, but when present, it and primarily occurs at the anterior maxilla in the head and neck area or in the nasal cartilage. Chondrosarcoma in the temporomandibular joint (TMJ) area is exceptionally rare, and only 30 cases have been reported in the literature[@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38]. Treatment of chondrosarcoma of the TMJ is often challenging and might be related to the presence of associated vital structures, which include the facial nerve, parotid gland, and the close proximity to the cranial base. Herein we present a case of a large chondrosarcoma in the TMJ area.

II. Case Report
===============

A 47-year-old woman with right facial swelling, suddenonset occlusal discrepancy, and trismus with a lobulated mass in the right preauricular area was referred to our clinic.([Fig. 1. A-C](#F1){ref-type="fig"}; The clinical and radiographic data have used under the agreement of her.) The patient had no spontaneous pain or facial paralysis. Clinically, the lesion was hard and tender and covered with normal skin. Computed tomography showed a large mass approximately 8.5×6.0 cm in size arising adjacent to the lateral pterygoid plate and condyle, with thinning of the cranial base and involving both the right lateral pterygoid and medial pterygoid muscles. Bone resorption from the right condyle and pterygoid plate was also observed.([Fig. 1. D-G](#F1){ref-type="fig"}) There was no significant lymph node enlargement detected either on clinical or radiologic analysis. Open biopsy was performed using a preauricular incision. On histology, cartilage cells were variable and bizarre. Heterogeneous tumor cells with cellular polymorphism were embedded in the chondrocyte lacuna in the mucinous or chondroid stroma. Based on the above findings, a diagnosis of grade 1 chondrosarcoma was made.

Surgical treatment was planned; due to the large mass involving the condyle, glenoid fossa, and cranial base with adjacent tissues, an extraoral approach with an extended preauricular incision, combined with a submandibular incision was used. The mass was dissected and surgically resected from adjacent perilesional tissue in a single block, and portions of the facial nerve involved in the mass were sacrificed. During surgery, for functional reconstruction of the facial nerve, the great auricular nerve was grafted to the damaged facial nerve. The auricular nerve graft was intentionally cut and ligated to both ends of the damaged facial nerve under microscopy. Part of the cranial bone base was also resected; fortunately, there was no invasion of the dura.([Fig. 2](#F2){ref-type="fig"}) The excised mass measured 8.5×6.5 cm in size with an intact synovial membrane and disk, and there appeared to be glistening cartilaginous tissue with a grayish-white pattern on the cut surface.([Fig. 3. A](#F3){ref-type="fig"})

After surgery, the patient experienced anesthesia in the temporal, buccal, and zygomatic branch regions and hypoesthesia in the mandibular and cervical branch. The motor nerve was also damaged; thus, movement of the right side of the forehead and corner of the mouth was barely detectable, but she could close her right eye, although this occurred much slower compared to the left eye.

Microscopic examination of sections stained with H&E revealed chondrocytes with irregular nuclei. Heterogeneous tumor cells embedded in the chondrocyte lacuna in the mucinous or chondroid stroma were also observed. The cells were composed of a diffuse proliferation of atypical chondrocytic cells in a myxoid or chondroid matrix where granular calcified materials were scattered and showed cellular pleomorphism with a bizarre nucleus appearance. Mitosis was observed in some areas.([Fig. 3. B, 3. C](#F3){ref-type="fig"}) Histological diagnosis was a low grade (grade I) chondrosarcoma without perineural, vascular, or lymph node invasion.

Due to the large size of the tumor, it was difficult to obtain sufficient marginal clearance. The patient was referred to a radiation oncologist for adjunctive radiation therapy due to the close margin. The radiation was delivered in a daily single dose of 1.8 Gy, total dose of 50.4 Gy on the right parapharyngeal space and a total dose of 10.8 Gy on the right infratemporal fossa area. After radiation therapy, radiographic and clinical examinations during the follow-up period showed no signs of recurrence. The patient is a young woman, and esthetic outcomes were very important for her. She desired reconstructive surgery to address the soft tissue defect in the right preauricular area as early as possible.([Fig. 4](#F4){ref-type="fig"}) Subsequently, reconstruction was performed with a fibular osteocutaneous free flap 8 months after the first surgery. The condyle was reconstructed with fibular bone, and the soft tissue depression in the preauricular area was augmented with a vascularized flap. Facial nerve weakness improved clinically as the damaged nerve and grafted preauricular nerve regenerated and healed.([Fig. 5](#F5){ref-type="fig"}) An electromyogram was needed to evaluate the facial nerve but was not performed because the patient refused any examination of the facial nerve.

III. Discussion
===============

Chondrosarcoma is a malignant tumor that originates in cartilaginous cells and that remains malignant throughout its evolution. Chondrosarcoma represents 10% to 20% of all malignant bone tumors, and only 1% to 12% originate in the head and neck region[@B3][@B4]. The most common site in the head and neck is the larynx, followed by the mandible, nasal cavity, and maxilla[@B5]. Chondrosarcoma in the TMJ area is rare, with only 30 cases reported in the literature[@B2][@B3][@B4][@B5][@B6][@B7][@B8][@B9][@B10][@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36][@B37][@B38]; all are presented in [Table 1](#T1){ref-type="table"}.

In previous reports, the mean age of patients with chondrosarcoma in the TMJ area was 38 to 48 years with no or slight female sex predominance. These characteristics vary from chondrosarcomas that occur in the head and neck area[@B15][@B33].

A major symptom of chondrosarcoma in the TMJ area is swelling in the preauricular region, followed by pain and trismus[@B5]. The duration of symptoms before final diagnosis is generally 3 to 24 months[@B17], although several studies have reported a duration of 6 to 8 years[@B23].

For accurate diagnosis, conventional radiographic investigation and computed tomography are helpful, but there are no unique pathognomonic findings in chondrosarcoma[@B34], which appears as a mass with single or multiple radiolucent areas that can involve a calcified mass with a condylar deformity, bone destruction, erosion of adjacent bone, condylar resorption, and sometimes cranial invasion. In most cases, increases in the articular space and the length of the condylar neck with radiopacity of the condyle are observed[@B5]. In many chondrosarcomas of the TMJ, radiographic evidence of widening of the joint space has been reported[@B35]. In this case report, joint space widening was also observed in computed tomography.

Histopathologically, chondrosarcoma of the TMJ area is similar to that of the head and neck areas or pelvis, ribs, or other regions. The lesions are microscopically lobulated with cellular neoplasms, hyaline cartilaginous proliferation, and sarcomatous stroma that contain stellate. The presence of mitotic figures is rare; therefore, their absence cannot rule out the diagnosis of chondrosarcoma. Criteria for diagnosis include an increase in the number of cells, expansion of cells, and formation of giant or binucleated cells[@B3]. Chondrosarcoma is classified into grade I, II, or III based on the frequency of mitosis, cellularity, and nucleus size[@B36]. However, distinguishing the grade is difficult because the grading system is derived from other joint chondrosarcomas, not solely from temporomandibular area chondrosarcomas[@B20].

The reported 5-year survival rate is 44% to 54.6%, and 10-year rate is 28%[@B32]. Murayama et al.[@B15] reported that 8 of 20 patients died 5 months to 6 years after primary treatment. Although Evans et al.[@B36] reported that the pathological grade was a useful prognostic factor, Saito et al.[@B33] reported that grade was not related to prognosis. Conversely, metastasis is related to histological grade; in grade II, the reported metastasis rate is 10%, while that in grade III is 71%. There were no reports of metastasis in grade I chondrosarcoma. Local recurrence is more common than distant metastasis and is related to tumor grade. Metastasis usually occurs in limbs and lungs, and regional lymph node metastasis is uncommon[@B20]. However, the most important factor in prognosis is resectability.

Wide local resection is the first choice of treatment, and neck node dissection is usually unnecessary because of the low incidence of regional lymph node metastasis[@B37]. Chondrosarcoma is traditionally regarded as radioresistant, and radiation therapy is best reserved for high-grade lesions. However, a recent study reported that it can be radiosensitive and potentially radiocurable. However, radiation therapy is generally used as an adjunct treatment and not as a single treatment modality. Thus, the primary role of irradiation is to treat unresectable areas or incompletely resected lesions after surgery. Use of chemotherapy is limited in chondrosarcoma but can be applied as an adjuvant therapy in cases with aggressive behavior, rapid local recurrence, or high grade[@B38].

In other reports, the tumor size was usually less than 3.0 to 4.0 cm. One case reported a 5.0-cm sized mass that was reconstructed with a rectus free flap[@B35]. In our case, the lesion size was 8.5 cm, which is exceptionally large for oral and maxillofacial surgery, making it difficult to obtain appropriate marginal clearance. Resection resulted in a large defect on the face and associated esthetic and functional problems. Therefore, radiation therapy and reconstructive surgery were required.

In our case, an enlarging mass and widening of the joint space in computed tomography were helpful to diagnose the chondrosarcoma before open biopsy. Wide local resection was attempted, with facial nerve sacrifice, but it was difficult to obtain a clear margin due to the large-sized mass; adjunctive radiation therapy was performed, and there was no sign of recurrence after follow-up for 8 months. Because of the large mandible defect of the condyle, glenoid fossa, and soft tissue in the right preauricular area, we used a fibular osteocutaneous free flap to reconstruct the mandible. This flap has relatively low donor morbidity and provided a good esthetic outcome.

In conclusion, chondrosarcoma of the TMJ is a very rare event. In our patient, because of the large mass, which was related to glenoid fossa involvement, the cranial base, facial nerve, and condyle were also involved. Using an extraoral approach, the mass was dissected and resected in a single block, and the sacrificed facial nerve was repaired with a nerve graft. Reconstructive surgery was performed following radiation therapy, 8 months after the first surgery, using a fibular osteocutaneous free flap for optimal functional and esthetic results. The long-term prognosis and recovery of the facial nerve function will be reported in future work.
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![A-C. Frontal view of the patient before tumor resection. Right-side preauricular swelling, occlusal discrepancy and trismus on presentation. D-G. Low-enhanced tumor around the right condylar head on contrast-enhanced computed tomography and magnetic resonance imaging.](jkaoms-42-288-g001){#F1}

![The surgical process. An extraoral approach with an extended preauricular incision and submandibular incision was used to dissect and resect the large mass. The glenoid fossa and cranial base with adjacent tissues, facial nerve, and condyle were involved in the mass.](jkaoms-42-288-g002){#F2}

![A. Resected mass with the right condylar head. B, C. Atypical chondrocytic cells in myxoid or chondroid matrix (B; H&E staining, ×400), pleomorphism with bizarre nucleus appearance (C; H&E staining, ×50).](jkaoms-42-288-g003){#F3}

![Frontal view of the patient after tumor resection and before reconstruction. There was a soft tissue depression on the right side of the preauricular area.](jkaoms-42-288-g004){#F4}

![Frontal view of the patient after reconstruction. The soft tissue in the preauricular area was augmented with a vascularized flap. The left two pictures show partial improvement in facial nerve weakness after great auricular nerve graft.](jkaoms-42-288-g005){#F5}

###### Reported temporomandibular joint chondrosarcoma cases

![](jkaoms-42-288-i001)

  Study                            Publication year   Age (yr)   Sex   Symptom   Treatment          Follow-up (mo)
  -------------------------------- ------------------ ---------- ----- --------- ------------------ ----------------
  Gingrass[@B6]                    1954               46         F     SPT       Surgery            ND
  Lanier et al.[@B7]               1971               48         F     SPT       Surgery            Few
  Sudo et al.[@B8]                 1972               ND         ND    P         Surgery+RT         ND
  Richter et al.[@B9]              1974               75         M     SP        Surgery            12
  Tullio and D'Errico[@B10]        1974               17         F     S         Surgery            ND
  Kato et al.[@B11]                1975               ND         ND    SPT       Surgery            18
  Kato et al.[@B11]                1975               ND         ND    SPT       Surgery            4
  Nortjé et al.[@B12]              1976               40         M     SPT       Surgery            24
  Cadenat et al.[@B13]             1979               60         F     SP        Surgery            6
  Morris et al.[@B14]              1987               29         F     S         Surgery+RT         6
  Murayama et al.[@B15]            1988               30         M     SPT       Surgery+RT+Chemo   3
  Wasenko and Rosenbloom[@B16]     1990               49         F     SP        Surgery            ND
  Nitzan et al.[@B17]              1993               36         F     SPT       Surgery            84
  Merrill et al.[@B18]             1997               50         F     T         Surgery            18
  Giraud et al.[@B19]              1997               ND         ND    S         Surgery+RT         ND
  Sesenna et al.[@B20]             1997               60         F     ST        Surgery            60
  Ichikawa et al.[@B21]            1998               66         F     ST        Surgery            36
  Batra et al.[@B22]               1999               65         M     S         Surgery            ND
  Mostafapour and Futran[@B23]     2000               31         F     S         Surgery            ND
  Mostafapour and Futran[@B23]     2000               52         F     S         Surgery+RT         6
  Angiero et al.[@B24]             2007               64         F     SP        Surgery            96
  Yun et al.[@B25]                 2008               29         F     T         Surgery            ND
  Oliveira et al.[@B26]            2009               11         F     S         Surgery+Chemo      36.5
  Gallego et al.[@B5]              2009               54         M     SPT       Surgery+RT         16
  Garzino-Demo et al.[@B27]        2010               65         F     SP        Surgery            108
  González-Pérez et al.[@B28]      2011               57         ND    SP        Surgery            24
  Ramos-Murguialday et al.[@B29]   2012               45         M     S         Surgery            36
  Abu-Serriah et al.[@B30]         2013               48         M     P         Surgery            6
  Giorgione et al.[@B31]           2015               56         M     SPT       Surgery+RT         ND
  MacIntosh et al.[@B32]           2015               31         F     ST        Surgery            336
  Our case                         2016               47         F     ST        Surgery+RT         8

(ND: no data, F: female, M: male, S: swelling, P: pain, T: trismus, RT: radiation therapy, Chemo: chemotherapy)
